| Literature DB >> 32424296 |
Muhamad Thohar Arifin1, Yuriz Bakhtiar2, Erie B P S Andar2, Happy Kurnia B2, Dody Priambada2, Ajid Risdianto2, Gunadi Kusnarto2, Krisna Tsaniadi2, Jacob Bunyamin2, Ryosuke Hanaya3, Kazunori Arita3, Aris Catur Bintoro4, Koji Iida5, Kaoru Kurisu, Rofat Askoro2, Surya P Briliantika2, Zainal Muttaqin2.
Abstract
Approximately 26-30% of temporal lobe epilepsy (TLE) cases display a normal-appearing magnetic resonance image (MRI) leading to difficulty in determining the epileptogenic focus. This causes challenges in surgical management, especially in countries with limited resources. The medical records of 154 patients with normal-appearing MRI TLE who underwent epilepsy surgery between July 1999 and July 2019 in our epilepsy centre in Indonesia were examined. The primary outcome was the Engel classification of seizures. Anterior temporal lobectomy was performed in 85.1% of the 154 patients, followed by selective amygdalo-hippocampectomy and resection surgery. Of 82 patients (53.2%), Engel Class I result was reported in 69.5% and Class II in 25.6%. The median seizure-free period was 13 (95% CI,12.550-13.450) years, while the seizure-free rate at 5 and 12 years follow-up was 96.3% and 69.0%, respectively. Patients with a sensory aura had better seizure-free outcome 15 (11.575-18.425) years. Anterior temporal lobectomy and selective amygdala-hippocampectomy gave the same favourable outcome. Despite the challenges of surgical procedures for normal MRI TLE, our outcome has been favourable. This study suggests that epilepsy surgery in normal MRI TLE can be performed in centres with limited resources.Entities:
Mesh:
Year: 2020 PMID: 32424296 PMCID: PMC7235248 DOI: 10.1038/s41598-020-64968-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of temporal lobe epilepsy patients with ‘normal-appearing’ MRI.
| Characteristics | Number (%) |
|---|---|
| Demography | |
| Male/Female | 91 (59.1)/63 (40.9) |
| Mean age at surgery | 23.1 ± 8.9 |
| Mean onset of seizure | 11.5 ± 6.4 |
| Mean duration until surgery | 11.7 ± 7.2 |
| Seizure Frequency | |
| Less than 12 episode/month | 137 (88.9) |
| 12 episodes or more/month | 17 (11.1) |
| Seizure Semiology | |
| FAS | 1 (0.6) |
| FIAS | 109 (70.8) |
| FIAS to GTCS | 44 (28.6) |
| Aura | |
| Absent/Present | 47 (30.5)/107 (69.5) |
| Aura Type | |
| Autonomic | 45 (29.2) |
| Sensory | 14 (9.1) |
| Mental affective | 33 (21.4) |
| Multiple | 15 (9.7) |
| Preoperative AEDs | |
| Mean daily consumption | 2.2 ± 0.9 |
FAS = focal aware seizure; FIAS = focal with impaired awareness seizure; GTCS = generalised tonic–clonic seizure; AED = anti-epileptic drugs.
Comparison of means of age at onset, age at surgery and length of diagnosis to postoperative seizure-free outcome.
| Status of Seizure in Final Follow-up | Length of Diagnosis in Years (SD) | ||
|---|---|---|---|
| Age at onset | Seizure | 12.114 (5.406) | 0.275 |
| Seizure-free | 10.591 (5.786) | ||
| Age at surgery | Seizure | 22.416 (8.032) | 0.894 |
| Seizure-free | 22.122 (9.363) | ||
| Duration of epilepsy | Seizure | 10.301 (4.749) | 0.406 |
| Seizure-free | 11.717 (7.690) | ||
Presurgical evaluations in temporal lobe epilepsy patients with ‘normal-appearing’ MRI.
| Presurgical Evaluations | Number (%) |
|---|---|
| PET scan | |
| Total | 43 (27.9) |
| Left hypometabolic | 24 (15.6) |
| Right hypometabolic | 16 (10.4) |
| Bilateral hypometabolic | 1 (0.6) |
| No lateralisation | 2 (1.3) |
| Scalp EEG | |
| Ictal | 104 (67.5) |
| Interictal | 50 (32.5) |
| EEG focus (side) | |
| Left side | 84 (54.5) |
| Right side | 43 (27.9) |
| Bilateral | 11 (7.1) |
| Diffuse | 4 (2.5) |
| Normal | 12 (8.0) |
Subdural EEG cases in normal MRI TLE (representative cases).
| No. | Sex | Age at onset/ Duration of Epilepsy (years) | Frequency of seizure (times/month) | Type of seizure | Type of aura | AED (mg/day) | Scalp EEG findings | Subdural EEG findings | Type of operation | Final outcome |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 7/8 | 2–4 | FIAS | Autonomic | CBZ 600 | Bilateral IEDs | Rt. Temporal IEDs | Rt. ATL | Engel Ia |
| 2 | F | 11/15 | 10–15 | FIAS | Multiple | VPA 1000, LTG 100, CLB 20 | No IEDs | Rt. Temporal IDs | Rt. ATL | Engel II |
| 3 | M | 19/26 | 4–5 | FIAS | Autonomic | PHT 300 | Bilateral IEDs | Rt. Temporal IDs | RT. ATL | Engel Ia |
| 4 | M | 14/5 | 8–12 | FIAS | Mental affective | CBZ 600, PHT 200, CLB 20 | No IEDs | Rt. Temporal IDs | Rt. ATL | Engel II |
| 5 | M | 12/33 | 3–4 | FIAS | Multiple | CBZ 600, CLB 20 | No IEDs | Lt. Temporal IDs | Lt. ATL | Engel Ia |
| 6 | F | 11/9 | 3–4 | FIAS | Multiple | OXC 600 | No IEDs | Rt. Temporal IDs | Rt. ATL | Engel Ia |
| 7 | M | 12/8 | 3–4 | FIAS to GTCS | Mental affective | VPA 750, PHT 200 | No IEDs | Lt. Temporal IDs | Lt. ATL | Engel Ia |
M: Male, F: Female, FIAS: Focal Impaired Awareness Seizure, FIAS to GTCS: Focal Impaired Awareness Seizure to Generalised Tonic–Clonic Seizure CBZ: Carbamazepine, VPA: Valproat, LTG: Lamotrigine, CLB: Clobazam, PHT: Phenytoine, OXC: Oxcarbazepine, IEDs: Interictal Discharges, ID: Ictal Discharges, Rt: Right, Lt: Left, ATL: Anterior Temporal Lobectomy.
Surgical approaches in temporal lobe epilepsy patients with ‘normal-appearing’ MRI.
| Surgical Approaches | Number (%) |
|---|---|
| Surgical side | |
| Left side | 93 (60.3) |
| Right side | 61 (39.7) |
| Surgery type | |
| ATL | 131 (85.1) |
| SAH | 16 (10.4) |
| Resection | 7 (4.5) |
| Electrocorticography (ECoG) | 7 (4.5) |
ATL = anterior temporal lobectomy; SAH = selective amygdalao-hippocampectomy.
Postoperative seizure outcomes.
| Seizure Outcomes | Number (%) |
|---|---|
| Engel Class | |
| I | 57 (69.5) |
| II | 21 (25.6) |
| III | 3 (3.7) |
| IV | 1(1.2) |
Median seizure-free time for (Type of operation, aura, seizure and overall subjects).
| Variable | Median Survival Time Year (95% CI) | ||
|---|---|---|---|
| Type of Operation | ATL | 14 (13.139–14.861) | 0.519 |
| SAH | 11 (8.171–13.829) | ||
| Type of Aura | Autonomic | 13 (11.539–14.461) | 0.013* |
| Sensory | 15 (11.575–18.425) | ||
| Mental Affective | 10 (5.011–14.989) | ||
| Multiple | 13 (12.487–13.513) | ||
| Type of Seizure | FIAS | 13 (12.397–13.603) | 0.826 |
| FIAS to GTCS | 13 (11.352–14.648) | ||
| Overall Median Survival Time for Seizure Freedom | 13 (12.550–13.450) | ||
*p < 0.05, statistically significant different each sub-variable.
Time between surgery and seizure-free status.
| Time since surgery (years) | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|
| Seizure-free chance (%) | 96.3 | 84.0 | 82.7 | 78.8 | 74.8 | 73.4 | 72.0 | 69.0 |
Figure 1Kaplan–Meier Plot on the chances of postoperative seizure-free period in the follow-up years.